A Study to Evaluate Once Daily Low Dose and High Dose Solabegron or Placebo Given for 12 Weeks to Treat Women With Symptoms of Overactive Bladder: Sudden Urge to Urinate, Frequent Urination Associated With Wetting Episodes (VEL-2001)
Public ClinicalTrials.gov record NCT03594058. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2b, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Oral Solabegron Modified Release Tablets in the Treatment of Overactive Bladder (OAB) in Adult Female Subjects
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a Phase 2b, multicenter, randomized, double-blind, placebo-controlled, parallel-group study designed to evaluate the efficacy, safety, and tolerability of solabegron modified release low dose or high dose tablets, compared to matched placebo, administered once daily for 12 weeks to adult female subjects with overactive bladder symptoms (frequency, urgency, and predominantly urgency incontinence) for at least 6 months.
Study identification
- NCT ID
- NCT03594058
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 1,413 participants
Conditions and interventions
Conditions
Interventions
- Solabegron modified release tablets, low dose Drug
- Solabegron modified release tablets, high dose Drug
- Matching Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 80 Years
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 9, 2018 (Actual)
- Primary completion
- Apr 29, 2019 (Actual)
- Completion
- May 2, 2019 (Actual)
- Last update posted
- Mar 2, 2020
2018 – 2019
United States locations
- U.S. sites
- 77
- U.S. states
- 24
- U.S. cities
- 64
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Velicept Investigative Site - Birmingham | Birmingham | Alabama | 35209 | — |
| Velicept Investigative Site - Birmingham | Birmingham | Alabama | 35215 | — |
| Velicept Investigative Site - Guntersville | Guntersville | Alabama | 35976 | — |
| Velicept Investigative Site - Saraland | Saraland | Alabama | 36571 | — |
| Velicept Investigative Site - Tucson | Tucson | Arizona | 85741 | — |
| Velicept Investigative Site - Tucson | Tucson | Arizona | 85745 | — |
| Velicept Investigative Site - Lincoln | Lincoln | California | 95648 | — |
| Velicept Investigative Site - North Hollywood | North Hollywood | California | 91606 | — |
| Velicept Investigative Site - Sacramento | Sacramento | California | 95864 | — |
| Velicept Investigative Site - San Diego | San Diego | California | 92108 | — |
| Velicept Investigative Site - San Diego | San Diego | California | 92111 | — |
| Velicept Investigative Site - Spring Valley | Spring Valley | California | 91978 | — |
| Velicept Investigative Site - Upland | Upland | California | 91786 | — |
| Velicept Investigative Site - Aurora | Aurora | Colorado | 80012 | — |
| Velicept Investigative Site - Englewood | Englewood | Colorado | 80113 | — |
| Velicept Investigative Site - New London | New London | Connecticut | 06320 | — |
| Velicept Investigative Site - Aventura | Aventura | Florida | 33180 | — |
| Velicept Investigative Site - Doral(2) | Doral | Florida | 33166 | — |
| Velicept Investigative Site - Doral | Doral | Florida | 33166 | — |
| Velicept Investigative Site - Edgewater | Edgewater | Florida | 32132 | — |
| Velicept Investigative Site - Hialeah | Hialeah | Florida | 33012 | — |
| Velicept Investigative Site - Hollywood | Hollywood | Florida | 33024 | — |
| Velicept Investigative Site - Lauderdale Lakes | Lauderdale Lakes | Florida | 33319 | — |
| Velicept Investigative Site - Miami | Miami | Florida | 33015 | — |
| Velicept Investigative Site - Miami | Miami | Florida | 33144 | — |
| Velicept Investigative Site - Miami | Miami | Florida | 33155 | — |
| Velicept Investigative Site - Miami Springs | Miami Springs | Florida | 33166 | — |
| Velicept Investigative Site - New Port Richey | New Port Richey | Florida | 34653 | — |
| Velicept Investigative Site - Palm Harbor | Palm Harbor | Florida | 34684 | — |
| Velicept Investigative Site - Pompano Beach | Pompano Beach | Florida | 33060 | — |
| Velicept Investigative Site - Tampa | Tampa | Florida | 33615 | — |
| Velicept Investigative Site - West Palm Beach | West Palm Beach | Florida | 33409 | — |
| Velicept Investigative Site - Atlanta | Atlanta | Georgia | 30328 | — |
| Velicept Investigative Site - Snellville | Snellville | Georgia | 30078 | — |
| Velicept Investigative Site - Crowley | Crowley | Louisiana | 70526 | — |
| Velicept Investigative Site - Metairie | Metairie | Louisiana | 70006 | — |
| Velicept Investigative Site - Brighton | Brighton | Massachusetts | 02135 | — |
| Velicept Investigative Site - North Dartmouth | North Dartmouth | Massachusetts | 02747 | — |
| Velicept Investigative Site - Saginaw | Saginaw | Michigan | 48605 | — |
| Velicept Investigative Site - Biloxi | Biloxi | Mississippi | 39531 | — |
| Velicept Investigative Site - Olive Branch | Olive Branch | Mississippi | 38654 | — |
| Velicept Investigative Site - La Vista | La Vista | Nebraska | 68128 | — |
| Velicept Investigative Site - Las Vegas | Las Vegas | Nevada | 89109 | — |
| Velicept Investigative Site - Las Vegas | Las Vegas | Nevada | 89117 | — |
| Velicept Investigative Site - Las Vegas | Las Vegas | Nevada | 89128 | — |
| Velicept Investigative Site - Edison | Edison | New Jersey | 08837 | — |
| Velicept Investigative Site - Raleigh | Raleigh | North Carolina | 27612 | — |
| Velicept Investigative Site - Fargo | Fargo | North Dakota | 58103 | — |
| Velicept Investigative Site - Dayton | Dayton | Ohio | 45439 | — |
| Velicept Investigative Site - Mustang | Mustang | Oklahoma | 73064 | — |
| Velicept Investigative Site - Oklahoma City | Oklahoma City | Oklahoma | 73120 | — |
| Velicept Investigative Site - Gresham | Gresham | Oregon | 97030 | — |
| Velicept Investigative Site - Lansdale | Lansdale | Pennsylvania | 19446 | — |
| Velicept Investigative Site - East Providence | East Providence | Rhode Island | 02914 | — |
| Velicept Investigative Site - Lincoln | Lincoln | Rhode Island | 02865 | — |
| Velicept Investigative Site - Charleston | Charleston | South Carolina | 29406 | — |
| Velicept Investigative Site - Charleston | Charleston | South Carolina | 29407 | — |
| Velicept Investigative Site - Fort Mill | Fort Mill | South Carolina | 29707 | — |
| Velicept Investigative Site - Spartanburg | Spartanburg | South Carolina | 29301 | — |
| Velicept Investigative Site - Chattanooga | Chattanooga | Tennessee | 37421 | — |
| Velicept Investigative Site - Jackson | Jackson | Tennessee | 38301 | — |
| Velicept Investigative Site - Knoxville | Knoxville | Tennessee | 37938 | — |
| Velicept Investigative Site - Austin | Austin | Texas | 78704 | — |
| Velicept Investigative Site - Austin | Austin | Texas | 78705 | — |
| Velicept Investigative Site - Bryan | Bryan | Texas | 77802 | — |
| Velicept Investigative Site - Carrollton | Carrollton | Texas | 75010 | — |
| Velicept Investigative Site - Dallas | Dallas | Texas | 75224 | — |
| Velicept Investigative Site - Fort Worth | Fort Worth | Texas | 76135 | — |
| Velicept Investigative Site - Georgetown | Georgetown | Texas | 78626 | — |
| Velicept Investigative Site - Houston | Houston | Texas | 77030 | — |
| Velicept Investigative Site - Houston | Houston | Texas | 77082 | — |
| Velicept Investigative Site - Plano(1) | Plano | Texas | 75024 | — |
| Velicept Investigative Site - Plano(2) | Plano | Texas | 75024 | — |
| Velicept Investigative Site - San Angelo | San Angelo | Texas | 76904 | — |
| Velicept Investigative Site - San Antonio | San Antonio | Texas | 78209 | — |
| Velicept Investigative Site - San Antonio | San Antonio | Texas | 78229 | — |
| Velicept Investigative Site - Sugar Land | Sugar Land | Texas | 77478 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03594058, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 2, 2020 · Synced Oct 27, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03594058 live on ClinicalTrials.gov.